Accelerate Diagnostics Inc.

1.36+0.2000+17.24%Vol 6.19M1Y Perf -86.29%
Jun 24th, 2022 16:00 DELAYED
BID1.36 ASK1.47
Open1.15 Previous Close1.16
Pre-Market- After-Market1.43
 - -  0.07 5.15%
Target Price
5.00 
Analyst Rating
Hold 3.00
Potential %
267.65 
Finscreener Ranking
★★★★     53.49
Insiders Trans % 3/6/12 mo.
-100/50/78 
Value Ranking
★★     46.03
Insiders Value % 3/6/12 mo.
-100/88/98 
Growth Ranking
★★★★     60.59
Insiders Shares Cnt. % 3/6/12 mo.
-100/57/93 
Income Ranking
 —    -
Price Range Ratio 52W %
9.77 
Earnings Rating
Strong Buy
Market Cap108.03M 
Earnings Date
4th Aug 2022
Alpha-0.06 Standard Deviation0.22
Beta1.92 

Today's Price Range

1.111.54

52W Range

0.50209.28

5 Year PE Ratio Range

-13.00-11.10

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Week
56.32%
1 Month
147.90%
3 Months
-7.48%
6 Months
-73.49%
1 Year
-86.29%
3 Years
-93.14%
5 Years
-95.50%
10 Years
-

TickerPriceChg.Chg.%
AXDX1.360.200017.24
AAPL141.663.39002.45
GOOG2 370.76117.07005.19
MSFT267.708.84003.41
XOM86.901.69001.98
WFC40.762.86007.55
JNJ182.292.63001.46
FB196.640.99000.51
GE67.083.01004.70
JPM117.323.40002.98
Financial StrengthValueIndustryS&P 500US Markets
6.40
7.40
0.93
12.85
-4.50
Leverage Ratio -1.60
ProfitabilityValueIndustryS&P 500US Markets
-3.90
-451.90
-431.60
-1 072.90
-
RevenueValueIndustryS&P 500US Markets
12.22M
0.15
17.79
56.68
Earnings HistoryEstimateReportedSurprise %
Q01 2022-0.32-0.2521.88
Q04 2021-0.30-0.2323.33
Q03 2021-0.35-0.1557.14
Q02 2021-0.35-0.36-2.86
Q01 2021-0.33-0.41-24.24
Q04 2020-0.31-0.33-6.45
Q03 2020-0.33-0.330.00
Q02 2020-0.34-0.35-2.94
Earnings Per EndEstimateRevision %Trend
6/2022 QR-0.330.00-
9/2022 QR-0.340.00-
12/2022 FY-1.330.00-
12/2023 FY-1.360.00-
Next Report Date4th Aug 2022
Estimated EPS Next Report-0.33
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume6.19M
Shares Outstanding79.44K
Shares Float51.28M
Trades Count7.00K
Dollar Volume8.42M
Avg. Volume1.48M
Avg. Weekly Volume1.52M
Avg. Monthly Volume1.88M
Avg. Quarterly Volume1.05M

Accelerate Diagnostics Inc. (NASDAQ: AXDX) stock closed at 1.36 per share at the end of the most recent trading day (a 17.24% change compared to the prior day closing price) with a volume of 6.19M shares and market capitalization of 108.03M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 275 people. Accelerate Diagnostics Inc. CEO is John Phillips.

The one-year performance of Accelerate Diagnostics Inc. stock is -86.29%, while year-to-date (YTD) performance is -73.95%. AXDX stock has a five-year performance of -95.5%. Its 52-week range is between 0.502 and 9.28, which gives AXDX stock a 52-week price range ratio of 9.77%

Accelerate Diagnostics Inc. currently has a PE ratio of -0.80, a price-to-book (PB) ratio of 89.93, a price-to-sale (PS) ratio of 5.65, a price to cashflow ratio of 213.80, a PEG ratio of 2.32, a ROA of -82.99%, a ROC of -51.28% and a ROE of 109.87%. The company’s profit margin is -%, its EBITDA margin is -431.60%, and its revenue ttm is $12.22 Million , which makes it $0.15 revenue per share.

Of the last four earnings reports from Accelerate Diagnostics Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.33 for the next earnings report. Accelerate Diagnostics Inc.’s next earnings report date is 04th Aug 2022.

The consensus rating of Wall Street analysts for Accelerate Diagnostics Inc. is Hold (3), with a target price of $5, which is +267.65% compared to the current price. The earnings rating for Accelerate Diagnostics Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Accelerate Diagnostics Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Accelerate Diagnostics Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 13.07, ATR14 : 0.18, CCI20 : 206.10, Chaikin Money Flow : 0.19, MACD : 0.09, Money Flow Index : 84.80, ROC : 18.26, RSI : 70.70, STOCH (14,3) : 81.25, STOCH RSI : 1.00, UO : 64.60, Williams %R : -18.75), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Accelerate Diagnostics Inc. in the last 12-months were: Hany Massarany (Buy at a value of $119 000), Jack Phillips (Option Excercise at a value of $0), Jack Phillips (Sold 115 559 shares of value $119 603 ), Jack W Schuler (Buy at a value of $10 470 125), Jack W. Schuler (Buy at a value of $10 470 125), Ron Price (Option Excercise at a value of $0), Ron Price (Sold 15 072 shares of value $14 771 ), Steven Reichling (Option Excercise at a value of $0), Steven Reichling (Sold 29 915 shares of value $29 317 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0 (0.00 %)
1 (33.33 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (100.00 %)
1 (100.00 %)
1 (33.33 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
1 (33.33 %)
Summary RatingHold
3.00
Hold
3.00
Hold
3.00

Accelerate Diagnostics Inc.

Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques.

CEO: John Phillips

Telephone: +1 520 365-3100

Address: 3950 South Country Club Road, Tucson 85714, AZ, US

Number of employees: 275

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

57%43%

Bearish Bullish

61%39%

Bearish Bullish

59%41%

TipRanks News for AXDX

Sat, 19 Mar 2022 09:11 GMT Accelerate Diagnostics (AXDX) Gets a Hold Rating from BTIG

- TipRanks. All rights reserved.

News

Stocktwits